Medtronic, BSX and St. Jude stand to gain from health law repeal; Stryker warns Euro recession will hit orthopedics business;

@FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev

> If the U.S. Supreme Court overturns the national health reform law, some are speculating that Medtronic ($MDT), Boston Scientific ($BSX) and St. Jude ($STJ) stocks will all see major gains. Story

> Wisconsin orthopedics startup Flex Biomedical is nearly finished raising $1 million toward development of a polymer-based synthetic injectable substance meant to treat pain and boost joint movement for osteoarthritis patients. Story

> Stryker ($SKY) warns that its European orthopedics business will likely take a hit in the second quarter, thanks to the deepening recession there. Story

> Devicemaker VenX is launching first-in-man trials for Reach, its in-development tech for treating varicose veins. Release

> The U.S. surgical navigation system device market will reach $195 million by 2016, according to a new Millennium Research Group study. Release

Biotech News

 @FierceBiotech: Ultrasound pill could replace daily injections. More | Follow @FierceBiotech

 @JohnCFierce: The cliffhanger: FDA set to decide on Arena's lorcaserin - (I suspect it's yes, but I wouldn't be flabbergasted by delay). Story | Follow @JohnCFierce

 @RyanMFierce: Why mobile tech isn't ideal for recruitment in clinical trials. More | Follow @RyanMFierce

> Covance blueprints $150M CRO expansion, ready to hire 465. More

> Supernus shares soar on epilepsy drug OK. Item

> Gates Foundation readies a round of tempting biotech investments. Article

Pharma News

 @FiercePharma: S&P gives Novartis props for R&D productivity, cites "good chance" of "at least stable" sales despite Diovan loss. Report | Follow @FiercePharma

> Merck, AstraZeneca rejig stomach-drug partnership. Story

> PDUFA goes to the president. News

> Amylin shareholder sues board for self-enrichment. News

Drug Delivery News

 @DamianFierce: With the diabetes market burgeoning around the globe, Fierce takes a look at the top 5 insulin-delivery techs to watch. Special Report | Follow @DamianFierce

> Nanoparticles could help block herpes infection. News

> Cholesterol boosts cancer nanotherapy. Article

> Researchers cook up sugar-based capsules for drug delivery. Item

> West teams with Amgen for injectable delivery. Story

Biomarkers News

> Pregnancy biomarkers linked with long-term cardiovascular risk. Story

> Biomarker might cut unneeded thyroid surgery. Article

> Alzheimer's blood test moves closer. News

> FDA approves Beckman Coulter's prostate blood test. More

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.